Oficinas Centrales
2300 Riverchase Center
Birmingham, AL 35244

tel.: 888.246.8338
tel.: 205.967.7880
fax: 205.870.0304

BioHorizons Canada
21 Amber Street, Unit #6
Markham, Ontario L3R 4Z3

tel.: 866.468.8338
fax: 905.944.1894

BioHorizons Chile, S.A.
Av. Manquehue Norte 1337 Of. 31

tel.: +56 (2) 23619519
fax: +56 (2) 361.9521

BioHorizons Italia Srl
Via Ettore Cristoni, 88
40033 Casalecchio di Reno (BO) Italy

numero verde +800.063.040
tel. +
fax +

Spanish Office
BioHorizons España
Calle Oruro, 9
Madrid, 28016

tel.: +34.91.713.10.84
fax: +34.91.355.83.75

BioHorizons UK
Richmond House
Oldbury Road
Berkshire RG12 8TQ
Reino Unido

tel.: +44 (0)1344 752560
fax: +44 (0)1344 868049

Grafton® DBM

Grafton DBM

Grafton DBM

Grafton DBM incorporates potent DBF (demineralized bone fibers) technology to ensure superior osteoconductivity. With more than 20 years of clinical history, Grafton DBM gives you the ability to preserve bone height and width.1 Proven in published, peer reviewed clinical studies, Grafton DBM in multiple forms gives clinicians options for bone grafting procedures.2

  • Indicated as a bone void filler, bone graft extender, and bone graft substitute3
  • Available in multiple forms to give the desired handling characteristics for multiple clinical indications

Grafton DBM

applications include4

  • relleno de alveolos post-extracción
  • elevación de la cresta y el seno
  • bone augmentation around implants
  • defectos óseos
  • composite grafting with MinerOss
  • periodontal regeneration
Grafton DBM product

Grafton DBM cases

extraction socket preservation

grafting around teeth with Grafton DBM
grafting around teeth with Grafton DBM
Grafton DBM histology


  1. Histologic analysis of implant sites after grafting with demineralized bone matrix putty and sheets. Callan, D.P., Salked, S.L., Scarborough, N.L. Implant Dent. 2009;9(1):36-42.
  2. Grafton DBM forms and Grafton Plus DBM Paste are FDA 510(k) cleared for use as a bone void filler, bone graft extender and bone graft substitute.
  3. FDA 510(k) K051188 and K051195 Indications for Use statements and summaries of safety and effectiveness for use as a bone void filler, bone graft extender and bone graft substitute.
No disponible en todos los países.